Clinical Trials Directory

Trials / Completed

CompletedNCT04188821

Reduction of Seroma and Improvement of QoL in Breast Reconstruction With Tissue Expander

Reduction of Seroma and Improvement of Quality of Life After Early Drain Removal in Immediate Breast Reconstruction With Tissue Expander. Preliminary Report of a Randomized Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
124 (actual)
Sponsor
University of Foggia · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The experimental hypothesis of this randomized controlled study was to demonstrate that early drain removal in patients who underwent immediate breast reconstruction with tissue expander is a safety procedure to improving clinical outcomes and quality of life (QoL). The mechanism of action underlying the proposed approach was intuitive. The early drain removal allows to: 1) avoid continuous seroma development caused by active suction of drain (stopping the circle "drain itself may perpetuate the drainage" with vacuum mechanism); 2) reduce the risks connected to "foreign body reaction" as tissue inflammation and infection; 3) improve QoL reducing pain, length of hospital stay and limitations of daily activities.

Conditions

Interventions

TypeNameDescription
PROCEDUREbreast drain removalInvestigators remove the drains when the suction drain flow was less than 30 ml/day for at least 2 days or at discharge, with no further signs of infection, fluid collection or impaired wound healing ("complicated", see below). Ultimately, we removed drains 3 weeks postoperatively (21 days post op) even if the flow was higher than 30 ml/day. However, leakage or severe patient discomfort led to immediate drain removal at any time during postoperative care.

Timeline

Start date
2016-09-01
Primary completion
2018-03-31
Completion
2018-12-31
First posted
2019-12-06
Last updated
2019-12-10

Source: ClinicalTrials.gov record NCT04188821. Inclusion in this directory is not an endorsement.